Cryptococcal meningoencephalitis associated with the long-term use of ruxolitinib

被引：23
作者：
Chen, Chih-Cheng [1 ,2 ]
Chen, Yi-Yang [1 ]
Huang, Cih-En [1 ]
机构：
[1] Chang Gung Mem Hosp, Dept Med, Div Hematol & Oncol, Chiayi, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
来源：
ANNALS OF HEMATOLOGY | 2016年 / 95卷 / 02期
关键词：
Cryptococcus; Meningitis; Myeloproliferative neoplasm; Ruxolitinib; Myelofibrosis; HIV-seronegative; JAK INHIBITION; CELL-FUNCTION; MYELOFIBROSIS;
D O I：
10.1007/s00277-015-2532-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：361 / 362
页数：2
相关论文
共 10 条
[1]   Bilateral Toxoplasmosis Retinitis Associated with Ruxolitinib [J].
Goldberg, Roger A. ;
Reichel, Elias ;
Oshry, Lauren J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (07) :681-683
[2]   JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis [J].
Harrison, Claire ;
Kiladjian, Jean-Jacques ;
Al-Ali, Haifa Kathrin ;
Gisslinger, Heinz ;
Waltzman, Roger ;
Stalbovskaya, Viktoriya ;
McQuitty, Mari ;
Hunter, Deborah S. ;
Levy, Richard ;
Knoops, Laurent ;
Cervantes, Francisco ;
Vannucchi, Alessandro M. ;
Barbui, Tiziano ;
Barosi, Giovanni .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :787-798
[3]   Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis? [J].
Heine, Annkristin ;
Brossart, Peter ;
Wolf, Dominik .
BLOOD, 2013, 122 (23) :3843-3844
[4]   The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo [J].
Heine, Annkristin ;
Held, Stefanie Andrea Erika ;
Daecke, Solveig Nora ;
Wallner, Stephanie ;
Yajnanarayana, Sowmya Parampalli ;
Kurts, Christian ;
Wolf, Dominik ;
Brossart, Peter .
BLOOD, 2013, 122 (07) :1192-1202
[5]   MECHANISMS OF DISEASE JAKs and STATs in Immunity, Immunodeficiency, and Cancer [J].
O'Shea, John J. ;
Holland, Steven M. ;
Staudt, Louis M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (02) :161-170
[6]   JAK Inhibition Impairs NK Cell Function in Myeloproliferative Neoplasms [J].
Schoenberg, Kathrin ;
Rudolph, Janna ;
Vonnahme, Maria ;
Yajnanarayana, Sowmya Parampalli ;
Cornez, Isabelle ;
Hejazi, Maryam ;
Manser, Angela R. ;
Uhrberg, Markus ;
Verbeek, Walter ;
Koschmieder, Steffen ;
Bruemmendorf, Tim H. ;
Brossart, Peter ;
Heine, Annkristin ;
Wolf, Dominik .
CANCER RESEARCH, 2015, 75 (11) :2187-2199
[7]   Hepatitis B virus reactivation associated with ruxolitinib [J].
Shen, Chien-Heng ;
Hwang, Cih-En ;
Chen, Yi-Yang ;
Chen, Chih-Cheng .
ANNALS OF HEMATOLOGY, 2014, 93 (06) :1075-1076
[8]   A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis [J].
Verstovsek, Srdan ;
Mesa, Ruben A. ;
Gotlib, Jason ;
Levy, Richard S. ;
Gupta, Vikas ;
DiPersio, John F. ;
Catalano, John V. ;
Deininger, Michael ;
Miller, Carole ;
Silver, Richard T. ;
Talpaz, Moshe ;
Winton, Elliott F. ;
Harvey, Jimmie H., Jr. ;
Arcasoy, Murat O. ;
Hexner, Elizabeth ;
Lyons, Roger M. ;
Paquette, Ronald ;
Raza, Azra ;
Vaddi, Kris ;
Erickson-Viitanen, Susan ;
Koumenis, Iphigenia L. ;
Sun, William ;
Sandor, Victor ;
Kantarjian, Hagop M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (09) :799-807
[9]   Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib [J].
Wathes, Rowan ;
Moule, Simon ;
Milojkovic, Dragana .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :197-198
[10]   An Opportunistic Infection Associated With Ruxolitinib, a Novel Janus Kinase 1,2 Inhibitor [J].
Wysham, Nicholas G. ;
Sullivan, Donald R. ;
Allada, Gopal .
CHEST, 2013, 143 (05) :1478-1479
1